Uncertainty looms large.
Despite falling interest rates, debt remains a sensitive issue.
Funded status of a typical Canadian plan increased on a solvency and accounting basis.
Costly new drugs are proliferating.
Small and mid-cap equities poised to shine in 2025.
The pension risk transfer market is benefiting greatly.
Net income declined 29% in the fourth quarter of the fiscal year, ending October 31, 2024.
